CoChat
Sign Up
Cited by 13

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Surface functionalized magnetic nanoparticles for targeted cancer therapy and diagnosis

Saifullah, Salim, Ali, Imdad, Kawish, Muhammad, El-Shabasy, Rehan M., Chen, Lei, El-Seedi, Hesham R.·2020·Metal Nanoparticles for Drug Delivery and Diagnostic Applications
DOI 10.1016/b978-0-12-816960-5.00012-4
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/b978-0-12-816960-5.00012-4

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 4 references

Research works printed but not linked: 79

  1. Bonnemain, 1998, Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications a review, J. Drug Target., 6, 167, 10.3109/10611869808997890 · DOI
  2. Boyer, 2010, The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications, NPG Asia Mater., 2, 23, 10.1038/asiamat.2010.6 · DOI
  3. Brigger, 2012, Nanoparticles in cancer therapy and diagnosis, Adv. Drug Deliv. Rev., 64, 24, 10.1016/j.addr.2012.09.006 · DOI
  4. Cao, 2004, Preparation and radiolabeling of surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy, J. Magn. Magn. Mater., 277, 165, 10.1016/j.jmmm.2003.10.022 · DOI
  5. Chen, 2016, Magnetically controlled release of recombinant tissue plasminogen activator from chitosan nanocomposites for targeted thrombolysis, J. Mater. Chem. B, 4, 2578, 10.1039/C5TB02579F · DOI
  6. Cheng, 2015, Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer’s disease mice using magnetic resonance imaging (MRI), Biomaterials, 44, 155, 10.1016/j.biomaterials.2014.12.005 · DOI
  7. Cherukuri, 2010, Targeted hyperthermia using metal nanoparticles, Adv. Drug Deliv. Rev., 62, 339, 10.1016/j.addr.2009.11.006 · DOI
  8. Chomoucka, 2010, Magnetic nanoparticles and targeted drug delivering, Pharmacol. Res., 62, 144, 10.1016/j.phrs.2010.01.014 · DOI
  9. Datta, 2016, Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich’s “magic (nano) bullet” for cancer theranostics?, Cancer Treat. Rev., 50, 217, 10.1016/j.ctrv.2016.09.016 · DOI · Paper page
  10. Davis, 2002, Non-viral gene delivery systems, Curr. Opin. Biotechnol., 13, 128, 10.1016/S0958-1669(02)00294-X · DOI · Paper page
  11. Dilnawaz, 2010, Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy, Biomaterials, 31, 3694, 10.1016/j.biomaterials.2010.01.057 · DOI
  12. Dobson, 2006, Magnetic nanoparticles for drug delivery, Drug Dev. Res., 67, 55, 10.1002/ddr.20067 · DOI
  13. Ferrari, 2005, Cancer nanotechnology: opportunities and challenges, Nat. Rev. Cancer, 5, 161, 10.1038/nrc1566 · DOI · Paper page
  14. Gao, 2008, Synergistic effect of thermotherapy in combination with chemotherapy on lung tumor A549 cells growth through activation of c-Jun N-terminal kinase and inhibition of heat shock protein70 expression, Wei sheng yan jiu=J. Hyg. Res., 37, 529
  15. Geng, 2007, Shape effects of filaments versus spherical particles in flow and drug delivery, Nat. Nanotechnol., 2, 249, 10.1038/nnano.2007.70 · DOI · Paper page
  16. Gunn, 2008, A multimodal targeting nanoparticle for selectively labeling T cells, Small, 4, 712, 10.1002/smll.200701103 · DOI
  17. Gupta, 2014, Methotrexate conjugated magnetic nanoparticle for targeted drug delivery and thermal therapy, J. Appl. Phys., 115, 17B516, 10.1063/1.4866080 · DOI
  18. Guven, 2015, Multiscale assembly for tissue engineering and regenerative medicine, Trends Biotechnol., 33, 269, 10.1016/j.tibtech.2015.02.003 · DOI
  19. Hachani, 2016, Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents, Nanoscale, 8, 3278, 10.1039/C5NR03867G · DOI
  20. Hamoudeh, 2008, Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer, Adv. Drug Deliv. Rev., 60, 1329, 10.1016/j.addr.2008.04.013 · DOI
  21. Harisinghani, 2003, Noninvasive detection of clinically occult lymph-node metastases in prostate cancer, N. Engl. J. Med., 348, 2491, 10.1056/NEJMoa022749 · DOI · Paper page
  22. Harris, 2003, Effect of pegylation on pharmaceuticals, Nat. Rev. Drug Discovery, 2, 214, 10.1038/nrd1033 · DOI · Paper page
  23. Hobbs, 1998, Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment, Proc. Natl. Acad. Sci. U.S.A., 95, 4607, 10.1073/pnas.95.8.4607 · DOI · Paper page
  24. Huang, 2009, Bioavailability of magnetic nanoparticles to the brain, J. Magn. Magn. Mater., 321, 1604, 10.1016/j.jmmm.2009.02.095 · DOI
  25. Huang, 2014, Magnetic Fe3O4 nanoparticles grafted with single-chain antibody (scFv) and docetaxel loaded β-cyclodextrin potential for ovarian cancer dual-targeting therapy, Mater. Sci. Eng.: C, 42, 325, 10.1016/j.msec.2014.05.041 · DOI
  26. Huang, 2016, Magnetic nanoparticle facilitated drug delivery for cancer therapy with targeted and image-guided approaches, Adv. Funct. Mater., 26, 3818, 10.1002/adfm.201504185 · DOI · Paper page
  27. Huang, 2017, Manipulation of surface hydrophobicity and charge of demulsifying bacteria using functional magnetic nanoparticles: a mechanistic study of demulsification performance, Energy Fuels, 31, 3295, 10.1021/acs.energyfuels.6b02674 · DOI
  28. Illés, 2015, Novel carboxylated PEG-coating on magnetite nanoparticles designed for biomedical applications, J. Magn. Magn. Mater., 380, 132, 10.1016/j.jmmm.2014.10.146 · DOI
  29. Ivkov, R., Denardo, S.J., Miers, L.A., Natarajan, A., Foreman, A.R., Gruettner, C., et al., 2006. Development of tumor targeting magnetic nanoparticles for cancer therapy. In: Proceedings of NSTI Nanotech, Boston, MA, pp. 21–24.
  30. Jian, 2012, Click chemistry: a new facile and efficient strategy for the preparation of Fe3O4 nanoparticles covalently functionalized with IDA-Cu and their application in the depletion of abundant protein in blood samples, Nanoscale, 4, 6336, 10.1039/c2nr31430d · DOI
  31. Jiao, Y., Liu, Y., Luo, D., Huck, W.T., Yang, D., 2018. Microfluidic assisted fabrication of clay microgels for cell-free protein synthesis. ACS Appl. Mater. Interfaces 10, 29308–29313. · DOI
  32. Kalaivani, 2018, Synthesis of chitosan mediated silver nanoparticles (Ag NPs) for potential antimicrobial applications, Front. Lab. Med, 2, 30, 10.1016/j.flm.2018.04.002 · DOI
  33. Kashkouli, 2018, Synthesis and characterization of aminotetrazole-functionalized magnetic chitosan nanocomposite as a novel nanocarrier for targeted gene delivery, Mater. Sci. Eng.: C, 89, 166, 10.1016/j.msec.2018.03.032 · DOI
  34. Khandhar, 2011, Monodispersed magnetite nanoparticles optimized for magnetic fluid hyperthermia: implications in biological systems, J. Appl. Phys., 109, 07B310, 10.1063/1.3556948 · DOI
  35. Kharisov, 2014, Solubilization, dispersion and stabilization of magnetic nanoparticles in water and non-aqueous solvents: recent trends, RSC Adv., 4, 45354, 10.1039/C4RA06902A · DOI
  36. Kievit, 2009, PEI–PEG–chitosan-copolymer-coated iron oxide nanoparticles for safe gene delivery: synthesis, complexation, and transfection, Adv. Funct. Mater., 19, 2244, 10.1002/adfm.200801844 · DOI
  37. Kim, 2009, Targeting to carcinoma cells with chitosan-and starch-coated magnetic nanoparticles for magnetic hyperthermia, J. Biomed. Mater. Res., A, 88, 1, 10.1002/jbm.a.31775 · DOI
  38. Kohler, 2006, Methotrexate-immobilized poly (ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery, Small, 2, 785, 10.1002/smll.200600009 · DOI
  39. Kolhatkar, 2013, Tuning the magnetic properties of nanoparticles, Int. J. Mol. Sci., 14, 15977, 10.3390/ijms140815977 · DOI
  40. Leal, 2018, Effect of the surface treatment on the structural, morphological, magnetic and biological properties of MFe2O4 iron spinels (M=Cu, Ni, Co, Mn and Fe), Appl. Surf. Sci., 455, 635, 10.1016/j.apsusc.2018.06.025 · DOI
  41. Li, 2011, Carboxymethylated dextran-coated magnetic iron oxide nanoparticles for regenerable bioseparation, J. Nanosci. Nanotechnol., 11, 10187, 10.1166/jnn.2011.5002 · DOI
  42. Li, 2011, Click-chemistry for nanoparticle-modification, J. Mater. Chem., 21, 16717, 10.1039/c1jm11558h · DOI
  43. Liu, 2014, Facile surface functionalization of hydrophobic magnetic nanoparticles, J. Am. Chem. Soc., 136, 12552, 10.1021/ja5060324 · DOI
  44. Lu, 2007, Magnetic nanoparticles: synthesis, protection, functionalization, and application, Angew. Chem. Int. Ed., 46, 1222, 10.1002/anie.200602866 · DOI
  45. Mccarthy, J.R., Kelly, K.A., Sun, E.Y. Weissleder, R., 2007. Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine (Lond) 2, 153–167. · DOI
  46. Mittal, 2014, Phytofabrication of nanoparticles through plant as nanofactories, Adv. Nat. Sci.: Nanosci. Nanotechnol., 5, 043002
  47. Moghimi, 1995, Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents, Adv. Drug Deliv. Rev., 17, 103, 10.1016/0169-409X(95)00043-7 · DOI
  48. Molday, 1982, Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells, J. Immunol. Methods, 52, 353, 10.1016/0022-1759(82)90007-2 · DOI
  49. Mornet, 2004, Magnetic nanoparticle design for medical diagnosis and therapy, J. Mater. Chem., 14, 2161, 10.1039/b402025a · DOI
  50. Mou, 2015, Applications of magnetic nanoparticles in targeted drug delivery system, J. Nanosci. Nanotechnol., 15, 54, 10.1166/jnn.2015.9585 · DOI
  51. Nguyen, 2018, Polyethylenimine-coated iron oxide magnetic nanoparticles for high efficient gene delivery, Appl. Nanosci., 8, 811, 10.1007/s13204-018-0775-z · DOI
  52. Nikiforov, 2007, Magnetic induction hyperthermia, Russ. Phys. J., 50, 913, 10.1007/s11182-007-0133-1 · DOI
  53. Pankhurst, 2003, Applications of magnetic nanoparticles in biomedicine, J. Phys. D: Appl. Phys., 36, R167, 10.1088/0022-3727/36/13/201 · DOI
  54. Patra, 2015, Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment, ACS Appl. Mater. Interfaces, 7, 9235, 10.1021/acsami.5b01786 · DOI
  55. Qu, 2011, Water-dispersible iron oxide magnetic nanoparticles with versatile surface functionalities, Langmuir, 27, 2271, 10.1021/la104471r · DOI
  56. Rajeshkumar, 2013, Intracellular and extracellular biosynthesis of silver nanoparticles by using marine bacteria Vibrio alginolyticus, Nanosci. Nanotechnol., 3, 21
  57. Rex, 2006, Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer, CA: Cancer J. Clin., 56, 160
  58. Rivera-Gil, 2012, The challenge to relate the physicochemical properties of colloidal nanoparticles to their cytotoxicity, Acc. Chem. Res., 46, 743, 10.1021/ar300039j · DOI
  59. Roth, 2015, Influencing factors in the CO-precipitation process of superparamagnetic iron oxide nano particles: a model based study, J. Magn. Magn. Mater., 377, 81, 10.1016/j.jmmm.2014.10.074 · DOI
  60. Schellenberger, 2004, Optimal modification of annexin V with fluorescent dyes, Chembiochem, 5, 271, 10.1002/cbic.200300741 · DOI
  61. Sheng, 2016, Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates, J. Controlled Release, 233, 181, 10.1016/j.jconrel.2016.05.015 · DOI
  62. Shubayev, 2009, Magnetic nanoparticles for theragnostics, Adv. Drug Deliv. Rev., 61, 467, 10.1016/j.addr.2009.03.007 · DOI
  63. Siami, 2018, Improvement of doxorubicin efficacy by conjugating to pH-sensitive copolymer-coated magnetic nanoparticles, Adv. Polym. Technol., 37, 202, 10.1002/adv.21657 · DOI
  64. Siegel, 2017, Cancer statistics, 2017, CA: Cancer J. Clin., 67, 7
  65. Singh, 2008, Safety of ferumoxytol in patients with anemia and CKD, Am. J. Kidney Dis., 52, 907, 10.1053/j.ajkd.2008.08.001 · DOI
  66. Solanki, A., Kim, J.D., Lee, K.-B., 2008. Nanotechnology for regenerative medicine: nanomaterials for stem cell imaging. Nanomedicine (Lond) 3, 567–578. · DOI
  67. Sun, 2008, In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes, Small, 4, 372, 10.1002/smll.200700784 · DOI
  68. Sun, 2014, In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model, Nanoscale, 6, 14343, 10.1039/C4NR03003F · DOI
  69. Uthaman, 2015, Polysaccharide-coated magnetic nanoparticles for imaging and gene therapy, BioMed Res. Int., 2015
  70. Veiseh, 2009, Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles, Small, 5, 256, 10.1002/smll.200800646 · DOI
  71. Venturelli, 2016, Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells, Sci. Rep., 6, srep21629, 10.1038/srep21629 · DOI
  72. Wang, 2014, HAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancer, Nanoscale Res. Lett., 9, 274, 10.1186/1556-276X-9-274 · DOI
  73. Wang, M.-H., Feng, L., Hang-Ping, Y., Wang, W., Sharma, S., Zhang, R., 2014b. Abstract LB-269: Anti-RON Antibody-Drug Maytansinoid Conjugates (Anti-RON ADC) as Potential Biotherapeutics for Targeted Colorectal Cancer Therapy. AACR. · DOI
  74. Wang, 2016, A multifunctional poly (curcumin) nanomedicine for dual-modal targeted delivery, intracellular responsive release, dual-drug treatment and imaging of multidrug resistant cancer cells, J. Mater. Chem. B, 4, 2954, 10.1039/C5TB02450A · DOI
  75. Weissleder, 2005, Cell-specific targeting of nanoparticles by multivalent attachment of small molecules, Nat. Biotechnol., 23, 1418, 10.1038/nbt1159 · DOI
  76. Wilczewska, 2012, Nanoparticles as drug delivery systems, Pharmacol. Rep., 64, 1020, 10.1016/S1734-1140(12)70901-5 · DOI · Paper page
  77. Yang, 2018, Multifunctional and stimuli-responsive magnetic nanoparticle-based delivery systems for biomedical applications, Adv. Ther., 1, 1800011, 10.1002/adtp.201800011 · DOI · Paper page
  78. Zhao, 2016, Fabrication of functional PLGA-based electrospun scaffolds and their applications in biomedical engineering, Mater. Sci. Eng.: C, 59, 1181, 10.1016/j.msec.2015.11.026 · DOI
  79. Khayat sarkar, 2011, Magnetic iron oxide nanoparticles, polyethylene glycol, surfactant, superparamagnetic, chemical co-precipitation, Int. J. Nanosci. Nanotechnol., 7, 197

Cited by

Sorted by citations

See all 13

Metadata

Authors
Saifullah, S., Ali, I., Kawish, M., El-Shabasy, R. M., Chen, L., & El-Seedi, H. R.
Venue
Metal Nanoparticles for Drug Delivery and Diagnostic Applications
Publisher
Elsevier
Published
2020
Pages
215-236
DOI
10.1016/b978-0-12-816960-5.00012-4
Cited by
13
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review